Int. J. Mol. Sci. 2013, 14(6), 11034-11060; doi:10.3390/ijms140611034

Current Status of Biomarkers for Prostate Cancer

1email, 2email, 1,* email and 1,* email
Received: 19 April 2013; in revised form: 13 May 2013 / Accepted: 14 May 2013 / Published: 24 May 2013
(This article belongs to the Special Issue Molecular Research in Urology)
View Full-Text   |   Download PDF [390 KB, uploaded 19 June 2014]
Abstract: Prostate cancer (PCa) is a leading cause of cancer-related death of men globally. Since its introduction, there has been intense debate as to the effectiveness of the prostate specific antigen (PSA) test as a screening tool for PCa. It is now evident that the PSA test produces unacceptably high rates of false positive results and is not prognostic. Here we review the current status of molecular biomarkers that promise to be prognostic and that might inform individual patient management. It highlights current efforts to identify biomarkers obtained by minimally invasive methods and discusses current knowledge with regard to gene fusions, mRNA and microRNAs, immunology, and cancer-associated microparticles.
Keywords: PSA; genomics; antibody microarrays; diagnostic biomarkers; genomics; prostate cancer; proteomics
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Velonas, V.M.; Woo, H.H.; Remedios, C.G.; Assinder, S.J. Current Status of Biomarkers for Prostate Cancer. Int. J. Mol. Sci. 2013, 14, 11034-11060.

AMA Style

Velonas VM, Woo HH, Remedios CG, Assinder SJ. Current Status of Biomarkers for Prostate Cancer. International Journal of Molecular Sciences. 2013; 14(6):11034-11060.

Chicago/Turabian Style

Velonas, Vicki M.; Woo, Henry H.; Remedios, Cristobal G.; Assinder, Stephen J. 2013. "Current Status of Biomarkers for Prostate Cancer." Int. J. Mol. Sci. 14, no. 6: 11034-11060.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert